Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
---|
03/11/2010 | WO2010026974A1 Process for production of sultone derivative |
03/11/2010 | WO2010026873A1 Novel compound ceramidastin, process for production thereof, and use thereof |
03/11/2010 | US20100062942 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
03/11/2010 | US20100062542 Antibody against aflatoxins, support using the antibody, method of immunologically detecting aflatoxins and method of concentrating and purifying aflatoxins |
03/11/2010 | US20100061948 Composition for skin whitening comprising artemisinine |
03/10/2010 | EP1651628B1 Antibiotic compound |
03/10/2010 | EP1556385B1 Heterocyclocarboxamide derivatives |
03/10/2010 | EP1445257B1 2h-1-benzopyran compounds for use in a photochromic material |
03/10/2010 | EP1023315B1 Methods and compositions for destruction of selected proteins |
03/10/2010 | CN101668761A Novel functional compounds with an isosorbide or isosorbide isomer core, production process and uses of these compounds |
03/10/2010 | CN101665497A Method for refining isosorbide by distillation and melt crystallization coupling technology |
03/09/2010 | US7674923 atorvastatin calcium epoxide dihydroxy (AED) is described; AED can be used as a standard or marker in determining the amount of AED in a sample |
03/04/2010 | WO2010024930A2 Cortistatin analogues and syntheses therof |
03/04/2010 | WO2010023594A1 Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives |
03/04/2010 | WO2010023322A1 Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate |
03/04/2010 | WO2009155020A3 Production of 5-membered and 6-membered cyclic esters of polyols |
03/04/2010 | US20100056807 Prostaglandin synthesis and intermediates for use therein |
03/04/2010 | US20100056618 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives |
03/04/2010 | US20100056605 Oxidative degradation products of atorvastatin calcium |
03/04/2010 | US20100056596 Resistance-repellent retroviral protease inhibitors |
03/04/2010 | CA2734814A1 Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate |
03/04/2010 | CA2733795A1 Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives |
03/03/2010 | EP1753858B1 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
03/03/2010 | EP1664056B1 Fused pentacyclic polyethers |
03/02/2010 | US7671219 Reacting a fullerene oxide and a carbonyl compound in the presence of a Lewis acid catalyst forming Fullerene 1,3-dioxolane; solar cells |
03/02/2010 | US7671088 Water-soluble etoposide analogs and methods of use thereof |
02/28/2010 | CA2676759A1 Prostaglandin synthesis and intermediates for use therein |
02/28/2010 | CA2639240A1 Prostaglandin synthesis and intermediates for use therein |
02/25/2010 | WO2010020663A1 New (poly)aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents |
02/25/2010 | WO2009132032A3 Sonic hedgehog modulators |
02/25/2010 | US20100048923 ATR Inhibitor |
02/25/2010 | US20100048882 N-(7-((3aR,4R,7R,7aR)-7-methoxy-6,6-dimethyl-2-oxo-tetrahydro-3aH- [1,3]dioxolo[4,5-c]pyran-4-yloxy)-2-oxo-2H-chromen-3-yl)acetamide; heat shock protein 90 inhibitors; gene expression inhibition; anticarcinogenic agents; neuroprotective agents |
02/25/2010 | CA2733688A1 New (poly)aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents |
02/24/2010 | EP2155755A1 Compositions comprising c-13 alkoxyether macrolide compounds and phenylpyrazole compounds |
02/24/2010 | EP2155754A1 Method for the production of dianhydrohexitol diesters |
02/24/2010 | EP2155178A1 Spiro compounds for treatment of inflammatory disorders |
02/24/2010 | CN101654410A Processes for preparing bicyclo (3.1.0) hexane derivatives, and intermediates thereto |
02/24/2010 | CN100591676C 2- and 2,5-substituted phenylketo-enols |
02/23/2010 | US7667052 Bioactive substance |
02/18/2010 | US20100041649 viricides used for for treating a human papillomavirus (HPV) viral infections, for inhibiting HPV DNA replication or for preventing prenatal transmission of HPV from mother to baby by administering to the mother prior to giving birth |
02/17/2010 | EP2152717A1 Processes for making epothilone compounds and analogs |
02/17/2010 | EP2152265A1 New method for preparing isofagomine and its derivatives |
02/17/2010 | CN101648959A Coumaronochromones compound and preparation and application thereof |
02/17/2010 | CN101648958A Preparation method of dianhydride monomer containing chiral dianhydro-hexitol |
02/17/2010 | CN101648957A Preparation method of sesamin phenol |
02/17/2010 | CN100590124C Tricyclic androgen receptor modulator compounds and method |
02/16/2010 | US7662976 Triptolide derivatives for modulation of apoptosis and immunosuppression |
02/16/2010 | US7662851 Use of specific cyklolignans |
02/11/2010 | WO2010015617A1 Process for producing carnosol from carnosic acid using hydrogen peroxide or peracids |
02/11/2010 | WO2009128087A3 A method for synthesis of dibenzylidene sorbitol in high yields |
02/11/2010 | US20100036138 Catalyst and method for producing carboxylic acid and/or carboxylic anhydride in the presence of the catalyst |
02/11/2010 | CA2735393A1 Novel compositions containing isolated tetrameric type a proanthocyanadin and methods of use and manufacture |
02/09/2010 | US7659404 Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors |
02/09/2010 | US7659308 Concentricolide and its derivatives, process for preparing them, pharmaceutical composition comprising the same and its use |
02/04/2010 | WO2010012761A1 Dimeric derivatives of artemisinin and application in anti-cancer therapy |
02/04/2010 | US20100029756 Novel compositions containing isolated tetrameric type a proanthocyanadin and methods of use and manufacture |
02/04/2010 | US20100029632 improved pharmacokinetics |
02/04/2010 | US20100029484 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use |
02/04/2010 | CA2730489A1 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use |
02/03/2010 | EP2149577A1 New stereospecific method for the preparation of dioxa-bicyclooctane compounds |
02/03/2010 | EP2149576A1 Isosorbide Nitrates having vasodilating activity |
02/03/2010 | CN100586950C Method for removing methylene of gingili wood phenols |
01/28/2010 | WO2010010933A1 Heterocyclidene-n-(3,4-dihydro-2(1h)-quinazolin-5-yl) acetamide derivative |
01/28/2010 | WO2010010101A1 Isosorbide nitrates having vasodilating activity |
01/28/2010 | WO2009147237A9 Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics |
01/28/2010 | WO2009145357A8 Benzo [1, 4] diazepines substituted at the 1-position by a ring, for use as antidepressants |
01/28/2010 | WO2009111428A4 Methods for synthesizing glycinols, glyceollins i and ii, compositions of selected intermediates, and therapeutic uses thereof |
01/28/2010 | WO2009019005A8 Tricyclic bridged cyclopentanedione derivatives as herbicides |
01/28/2010 | US20100022638 Isosorbide nitrates |
01/28/2010 | CA2734991A1 Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival |
01/28/2010 | CA2731574A1 Isosorbide nitrates having vasodilating activity |
01/27/2010 | EP2147921A1 Process for production of coumarin dimer compound |
01/27/2010 | EP2146998A1 Sorbitol conversion process |
01/27/2010 | CN101633661A Process for preparing sodium cantharidinate |
01/27/2010 | CN101633660A Novel abietane-type diterpene compound as well as preparation method and application thereof |
01/27/2010 | CN101633659A Method for concentrating and purifying sesamin |
01/26/2010 | CA2300407C 4-cyano-4-deformylsordarin derivatives |
01/21/2010 | WO2009115927A3 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
01/21/2010 | US20100016154 Imaging system |
01/21/2010 | US20100015149 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
01/20/2010 | CN100582111C Process for the production of the spiroglycol |
01/20/2010 | CN100582110C Cyclohexanone analog saturated triring(bridge)compound and its preparation method and uses |
01/20/2010 | CN100582097C Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors |
01/19/2010 | US7649099 two step processes of producing isosorbide from sorbitol; first step in presence of a solid acid catalyst; second step in presence of a second catalyst selected from sulfuric acid, phosphoric acid, hydrochloric acid and p-toluenesulfonic acid; cost efficiency, environmentally friendly; therapeutic uses |
01/19/2010 | US7649014 Inhibit uncoupling protein-2 (UCP2); treating deficient first-phase insulin secretion, non-insulin dependent diabetes mellitus, and ischemia |
01/19/2010 | US7649006 Synthesis of epothilones, intermediates thereto and analogues thereof |
01/19/2010 | CA2472115C Colorant compounds |
01/14/2010 | US20100010240 Synthesis of polycyclic procyanidins |
01/14/2010 | US20100010063 Heterocyclocarboxamide derivatives |
01/14/2010 | US20100009935 Resistance-repellent retroviral protease inhibitors |
01/13/2010 | EP2142521A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
01/13/2010 | CN100579981C 3,9-dioxaasterane compounds and preparation method and application thereof |
01/12/2010 | US7645891 E.g., 4-(2-methyl-3-oxo-hept-6-en-2-yl)-2,2-dimethyl-[1,3]-dioxane chemical intermediate; chemical/metabolic stabilization of microtubuli; antitumor, -carcinogenic agents; malignant melanoma, acute lymphocytic/myelocytic leukemia; angiogenesis inhibitors; antiinflammatory/-arthritic agents; psoriasis |
01/12/2010 | US7645863 Adding a second organic solvent to a concentrated moxidectin solution to obtain a weight ratio of 2:I to 6:I with respect to the first solvent; cooling and recovering crystals of 94-96% purity being 2-5% purer than the amorphous form; veterinary medicine; antithelmintics; parasiticides |
01/12/2010 | US7645768 Production of polyketides and other natural products |
01/12/2010 | CA2387675C Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
01/12/2010 | CA2346010C Derivatives of isosorbide mononitrate and its use as vasodilating agents with reduced tolerance |
01/07/2010 | US20100004441 N-(5-Membered Aromatic Ring)-Amido Anti-Viral Compounds |
01/07/2010 | US20100004234 Specific kinase inhibitors |
01/06/2010 | EP2139900A2 Novel functional compounds with an isosorbide or isosorbide isomer core, production process and uses of these compounds |